Next Article in Journal
Adjuvant Inhaled Corticosteroids in Community-Acquired Pneumonia: A Review Article
Next Article in Special Issue
Expert Group Recommendations on the Effective Use of Bolus Insulin in the Management of Type 2 Diabetes Mellitus
Previous Article in Journal
The Mechanisms for the Association of Cancer and Esophageal Dysmotility Disorders
Article

Mindfulness Meditation as Adjunctive Therapy to Improve the Glycemic Care and Quality of Life in Patients with Type 1 Diabetes

1
Society for Prevention and Awareness of Diabetes, Kanpur 208002, Uttar Pradesh, India
2
Regency Center for Diabetes Endocrinology & Research, Department of Endocrinology, Kanpur 208002, Uttar Pradesh, India
*
Author to whom correspondence should be addressed.
Academic Editor: Antoni Torres
Med. Sci. 2021, 9(2), 33; https://doi.org/10.3390/medsci9020033
Received: 2 April 2021 / Revised: 11 May 2021 / Accepted: 14 May 2021 / Published: 21 May 2021
(This article belongs to the Special Issue Contemporary Endocrinology)
Background: Mindfulness Meditation (MM) is known to improve glycemic control and enhance the quality of life (QoL) in type 2 diabetes (T2D) patients. Unfortunately, the role of meditation in type 1 diabetes (T1D) has not been studied extensively. Therefore, we conducted this study to determine the effect of MM on the glycemic control and QoL in people living with T1D. Methodology: Thirty-two adults living with T1D were equally randomized into intervention (meditation) and control groups. The glycemic control and QoL were assessed at the baseline and after six months of intervention. Results: A total of thirty-two adults (15 males, 46.9%; mean age 23.8 ± 6.6 years) with type 1 diabetes (mean diabetes duration 12.7 ± 6.2 years) participated in the study. At the end of six months, a statistically significant improvement was seen in the mean blood glucose level in the control group (222.4 ± 77.8 versus 182.6 ± 52.0; p = 0.007) and the intervention group (215.3 ± 50.1 versus 193.2 ± 31.8; p = 0.008). Additionally, there was a significant reduction in the total diabetes distress score in the intervention group (1.6 ± 0.3 versus 1.3 ± 0.3; p = 0.003), while no change was observed in the control group (1.6 ± 0.7 versus 1.7 ± 0.4; p = 0.762). A statistically significant improvement was noticed in the health and functioning domain in the intervention group (p = 0.023). Conclusions: An improvement in the glycemic control and quality of life of the patients was observed in our study. MM certainly plays an important role in attaining peace of mind and helps patients to channel their energy in a positive direction. View Full-Text
Keywords: Mindfulness Meditation; type 1 diabetes; quality of life Mindfulness Meditation; type 1 diabetes; quality of life
Show Figures

Figure 1

MDPI and ACS Style

Shukla, R.; Gupta, M.; Agarwal, N.; Bajpai, A. Mindfulness Meditation as Adjunctive Therapy to Improve the Glycemic Care and Quality of Life in Patients with Type 1 Diabetes. Med. Sci. 2021, 9, 33. https://doi.org/10.3390/medsci9020033

AMA Style

Shukla R, Gupta M, Agarwal N, Bajpai A. Mindfulness Meditation as Adjunctive Therapy to Improve the Glycemic Care and Quality of Life in Patients with Type 1 Diabetes. Medical Sciences. 2021; 9(2):33. https://doi.org/10.3390/medsci9020033

Chicago/Turabian Style

Shukla, Rishi, Manisha Gupta, Neha Agarwal, and Anurag Bajpai. 2021. "Mindfulness Meditation as Adjunctive Therapy to Improve the Glycemic Care and Quality of Life in Patients with Type 1 Diabetes" Medical Sciences 9, no. 2: 33. https://doi.org/10.3390/medsci9020033

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop